Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03107988 |
| Title | NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922) |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | New Approaches to Neuroblastoma Therapy Consortium |
| Indications | |
| Therapies | |
| Age Groups: | child | adult | senior |
| Covered Countries | USA | GBR | FRA | CAN |
CKB BOOST